Machatha Stephen 4
4 · Aldeyra Therapeutics, Inc. · Filed Aug 13, 2025
Insider Transaction Report
Form 4
Machatha Stephen
Chief Development Officer
Transactions
- Sale
Common Stock
2025-08-11$5.15/sh−22,073$113,713→ 221,799 total
Footnotes (3)
- [F1]These shares of common stock were sold in a transaction by the Reporting Person in order to cover tax withholding obligations upon the settlement of certain time-based restricted stock unit awards.
- [F2]Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $5.06 to $5.29. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Includes 7,101 shares of common stock acquired under the Issuer's Employee Stock Purchase Plan.